CGC
Price
$1.23
Change
-$0.01 (-0.81%)
Updated
Jun 27, 04:59 PM (EDT)
Capitalization
784.64M
42 days until earnings call
CRON
Price
$1.90
Change
-$0.02 (-1.05%)
Updated
Jun 27, 04:59 PM (EDT)
Capitalization
1B
41 days until earnings call
Interact to see
Advertisement

CGC vs CRON

Header iconCGC vs CRON Comparison
Open Charts CGC vs CRONBanner chart's image
Canopy Growth
Price$1.23
Change-$0.01 (-0.81%)
Volume$77.82K
Capitalization784.64M
Cronos Group
Price$1.90
Change-$0.02 (-1.05%)
Volume$3.36K
Capitalization1B
CGC vs CRON Comparison Chart in %
Loading...
CGC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CGC vs. CRON commentary
Jun 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGC is a Buy and CRON is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 27, 2025
Stock price -- (CGC: $1.24 vs. CRON: $1.91)
Brand notoriety: CGC: Notable vs. CRON: Not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: CGC: 122% vs. CRON: 44%
Market capitalization -- CGC: $784.64M vs. CRON: $1B
CGC [@Pharmaceuticals: Other] is valued at $784.64M. CRON’s [@Pharmaceuticals: Other] market capitalization is $1B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.8B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CGC’s FA Score shows that 0 FA rating(s) are green whileCRON’s FA Score has 0 green FA rating(s).

  • CGC’s FA Score: 0 green, 5 red.
  • CRON’s FA Score: 0 green, 5 red.
According to our system of comparison, CRON is a better buy in the long-term than CGC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CGC’s TA Score shows that 2 TA indicator(s) are bullish while CRON’s TA Score has 3 bullish TA indicator(s).

  • CGC’s TA Score: 2 bullish, 7 bearish.
  • CRON’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, CRON is a better buy in the short-term than CGC.

Price Growth

CGC (@Pharmaceuticals: Other) experienced а -3.88% price change this week, while CRON (@Pharmaceuticals: Other) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +113.87%. For the same industry, the average monthly price growth was +74.83%, and the average quarterly price growth was +80.55%.

Reported Earning Dates

CGC is expected to report earnings on Aug 08, 2025.

CRON is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+113.87% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRON($1.01B) has a higher market cap than CGC($785M). CRON YTD gains are higher at: -5.446 vs. CGC (-54.745). CRON has higher annual earnings (EBITDA): -71.8M vs. CGC (-1.02B). CRON has more cash in the bank: 862M vs. CGC (186M). CRON has less debt than CGC: CRON (2.55M) vs CGC (693M). CGC has higher revenues than CRON: CGC (362M) vs CRON (87.2M).
CGCCRONCGC / CRON
Capitalization785M1.01B78%
EBITDA-1.02B-71.8M1,424%
Gain YTD-54.745-5.4461,005%
P/E RatioN/AN/A-
Revenue362M87.2M415%
Total Cash186M862M22%
Total Debt693M2.55M27,145%
FUNDAMENTALS RATINGS
CGC vs CRON: Fundamental Ratings
CGC
CRON
OUTLOOK RATING
1..100
5319
VALUATION
overvalued / fair valued / undervalued
1..100
90
Overvalued
54
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9884
PRICE GROWTH RATING
1..100
6561
P/E GROWTH RATING
1..100
10081
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CRON's Valuation (54) in the Pharmaceuticals Other industry is somewhat better than the same rating for CGC (90) in the Agricultural Commodities Or Milling industry. This means that CRON’s stock grew somewhat faster than CGC’s over the last 12 months.

CRON's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as CGC (100) in the Agricultural Commodities Or Milling industry. This means that CRON’s stock grew similarly to CGC’s over the last 12 months.

CRON's SMR Rating (84) in the Pharmaceuticals Other industry is in the same range as CGC (98) in the Agricultural Commodities Or Milling industry. This means that CRON’s stock grew similarly to CGC’s over the last 12 months.

CRON's Price Growth Rating (61) in the Pharmaceuticals Other industry is in the same range as CGC (65) in the Agricultural Commodities Or Milling industry. This means that CRON’s stock grew similarly to CGC’s over the last 12 months.

CRON's P/E Growth Rating (81) in the Pharmaceuticals Other industry is in the same range as CGC (100) in the Agricultural Commodities Or Milling industry. This means that CRON’s stock grew similarly to CGC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CGCCRON
RSI
ODDS (%)
Bearish Trend 2 days ago
88%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
70%
Bullish Trend 2 days ago
71%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
83%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
75%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 22 days ago
78%
Bullish Trend 4 days ago
69%
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 18 days ago
84%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
75%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
CGC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
EIUTX16.34N/A
N/A
Eaton Vance Dividend Builder I
MRSKX25.33N/A
N/A
MFS Research International R6
MVGNX17.91N/A
N/A
MFS Low Volatility Global Equity R6
SREYX16.02N/A
N/A
SEI Real Estate Y (SIMT)
PGDRX11.62N/A
N/A
Principal Diversified Real Asset R3

CGC and

Correlation & Price change

A.I.dvisor indicates that over the last year, CGC has been closely correlated with SNDL. These tickers have moved in lockstep 77% of the time. This A.I.-generated data suggests there is a high statistical probability that if CGC jumps, then SNDL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CGC
1D Price
Change %
CGC100%
+0.81%
SNDL - CGC
77%
Closely correlated
+2.46%
ACB - CGC
64%
Loosely correlated
+8.67%
TLRY - CGC
63%
Loosely correlated
+4.72%
OGI - CGC
59%
Loosely correlated
+2.94%
CRON - CGC
58%
Loosely correlated
+1.06%
More

CRON and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRON has been closely correlated with SNDL. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if CRON jumps, then SNDL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRON
1D Price
Change %
CRON100%
+1.06%
SNDL - CRON
73%
Closely correlated
+2.46%
TLRY - CRON
61%
Loosely correlated
+4.72%
OGI - CRON
59%
Loosely correlated
+2.94%
CGC - CRON
58%
Loosely correlated
+0.81%
ACB - CRON
55%
Loosely correlated
+8.67%
More